NCT00430963View on ClinicalTrials.gov

IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines

PHASE3CompletedINTERVENTIONAL
Enrollment

256

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

April 30, 2007

Study Completion Date

November 30, 2007

Conditions
Glabellar Frown Lines
Interventions
DRUG

IncobotulinumtoxinA (Xeomin) (20 Units)

DRUG

Placebo

Trial Locations (1)

60318

Merz Pharmaceuticals GmbH, Frankfurt

Sponsors
All Listed Sponsors
lead

Merz Pharmaceuticals GmbH

INDUSTRY